Citation Impact
Citing Papers
Combined Inhibition of Both p110α and p110β Isoforms of Phosphatidylinositol 3-Kinase Is Required for Sustained Therapeutic Effect in PTEN-Deficient, ER+ Breast Cancer
2016
Lysine Acetylation Targets Protein Complexes and Co-Regulates Major Cellular Functions
2009 StandoutScience
Induction of interferon-stimulated gene expression and antiviral responses require protein deacetylase activity
2004 StandoutNobel
Signal transduction to hypoxia-inducible factor 1
2002 StandoutNobel
Combined biological therapy of breast cancer using monoclonal antibodies directed against HER2/ protein and vascular endothelial growth factor
2002
Hallmarks of Cancer: The Next Generation
2011 Standout
Activation of FOXO3a by the Green Tea Polyphenol Epigallocatechin-3-Gallate Induces Estrogen Receptor α Expression Reversing Invasive Phenotype of Breast Cancer Cells
2007
Levels of hypoxia‐inducible factor‐1α independently predict prognosis in patients with lymph node negative breast carcinoma
2003 StandoutNobel
Analysis of Hypoxia‐Inducible Factor 1α Expression and its Effects on Invasion and Metastasis
2007 StandoutNobel
Determination of binding constant of transcription factor myc–max/max–max and E-box DNA: the effect of inhibitors on the binding
2004
Reduced maternal expression of adrenomedullin disrupts fertility, placentation, and fetal growth in mice
2006 StandoutNobel
Estrogen Receptors: How Do They Signal and What Are Their Targets
2007 Standout
Estrogen receptors and human disease
2006 Standout
MYC on the Path to Cancer
2012 Standout
Targeting HIF-1 for cancer therapy
2003 StandoutNobel
Molecular mechanisms of epithelial–mesenchymal transition
2014 Standout
Enhanced expression of membrane phosphoproteins tyrosine phosphorylation in estrogen-induced kidney tumors
1992
The Biology of Cancer: Metabolic Reprogramming Fuels Cell Growth and Proliferation
2008 Standout
Skeletal Effects of Estrogen*
1994
Endometriosis
2009 Standout
Expression of the insulin‐like and platelet‐derived growth factor genes in human uterine tissues
1990
Molecular determinants of resistance to antiandrogen therapy
2003 Standout
Nerve growth factor (NGF) regulation of estrogen receptors in explant cultures of the developing forebrain
1996
Identification of an estrogen response element upstream of the human c-fosgene that binds the estrogen receptor and the AP-1 transcription factor
1990
Endocrine Disruptors: Can Biological Effects and Environmental Risks Be Predicted?
2002
New insights into the mechanisms of epithelial–mesenchymal transition and implications for cancer
2018 Standout
Vascular Endothelial Growth Factor and Angiogenesis
2004 Standout
Neonatal exposure to diethylstilbestrol permanently alters the basal and 17β-estradiol induced expression of c-fos proto-oncogene in mouse urethroprostatic complex
1997
Regulation of Hormone-Induced Histone Hyperacetylation and Gene Activation via Acetylation of an Acetylase
1999
The development of androgen-independent prostate cancer
2001 Standout
Uterine Insulin-Like Growth Factor-1: Regulation of Expression and Its Role in Estrogen-Induced Uterine Proliferation*
1990
Hypoxia-inducible factor–dependent breast cancer–mesenchymal stem cell bidirectional signaling promotes metastasis
2012 StandoutNobel
Role of Hypoxia-Inducible Factor 1 in Gastric Cancer Cell Growth, Angiogenesis, and Vessel Maturation
2004 StandoutNobel
Angiogenic Factors in Endometriosis
2002
Steroid-induced androgen receptor-oestradiol receptor beta-Src complex triggers prostate cancer cell proliferation
2000
Trastuzumab — Mechanism of Action and Use in Clinical Practice
2007 Standout
Levels of Hypoxia-Inducible Factor-1 During Breast Carcinogenesis
2001 StandoutNobel
Evaluation of Factors Related to Late Recurrence - Later than 10 Years after the Initial Treatment - in Primary Breast Cancer
2013 Standout
Serum response factor: master regulator of the actin cytoskeleton and contractile apparatus
2006
Paclitaxel plus Bevacizumab versus Paclitaxel Alone for Metastatic Breast Cancer
2007 Standout
Inhibition of the 17β-estradiol-induced and constitutive expression of the cellular protooncogene c-fos by 2,3,7,8-tetrachlorodibenzo-p-dioxin (TCDD) in the female rat uterus
1991
Sequence Requirements for Estrogen Receptor Binding to Estrogen Response Elements
1998
Phosphatidylinositol 3-Kinase/AKT-mediated Activation of Estrogen Receptor α
2001
Eicosanoids and cancer
2010 Standout
Similarities and distinctions in the mode of action of different classes of antioestrogens.
2000
Modern Synthetic Methods for Fluorine‐Substituted Target Molecules
2004 Standout
Endometriosis
2004 Standout
Genistein exerts estrogen-like effects in male mouse reproductive tract
1998
Production and Actions of Estrogens
2002 Standout
Palbociclib and Letrozole in Advanced Breast Cancer
2016 Standout
The PI3K Pathway in Human Disease
2017 Standout
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
Estradiol stimulates the biosynthetic pathways of breast cancer cells: Detection by metabolic flux analysis
2006
Receptor Activity-modifying Proteins 2 and 3 Have Distinct Physiological Functions from Embryogenesis to Old Age
2007 StandoutNobel
GREAT improves functional interpretation of cis-regulatory regions
2010 Standout
Estradiol Regulation of Insulin-Like Growth Factor-I Expression in Osteoblastic Cells: Evidence for Transcriptional Control
1991
Mechanisms of implantation: strategies for successful pregnancy
2012 Standout
Vascular endothelial growth factors are differentially regulated by steroid hormones and antiestrogens in breast cancer cells
1999
Alteration of reproductive function but not prenatal sexual development after insertional disruption of the mouse estrogen receptor gene.
1993 StandoutNobel
The Next Generation of Platinum Drugs: Targeted Pt(II) Agents, Nanoparticle Delivery, and Pt(IV) Prodrugs
2016 Standout
Biologic Correlates of 18Fluorodeoxyglucose Uptake in Human Breast Cancer Measured by Positron Emission Tomography
2002 StandoutNobel
Fluorine in Pharmaceutical Industry: Fluorine-Containing Drugs Introduced to the Market in the Last Decade (2001–2011)
2013 Standout
Combined vascular endothelial growth factor and TP53 status predicts poor response to tamoxifen therapy in estrogen receptor-positive advanced breast cancer.
2003
Ligand-dependent interactions of coactivators steroid receptor coactivator-1 and peroxisome proliferator-activated receptor binding protein with nuclear hormone receptors can be imaged in live cells and are required for transcription
2000 StandoutNobel
Interactions between endothelial nitric oxide synthase and sex hormones in vascular protection in mice
2002 StandoutNobel
The coregulator exchange in transcriptional functions of nuclear receptors
2000 Standout
Identification of a Functional Imperfect Estrogen-Responsive Element in the 5‘-Promoter Region of the Human Cathepsin D Gene
1997
Histone Acetyltransferases
2001 Standout
Vascular endothelial growth factor is modulated in vascular muscle cells by estradiol, tamoxifen, and hypoxia
2000
Estrogen Receptor β Inhibits Angiogenesis and Growth of T47D Breast Cancer Xenografts
2006
Vascular endothelial growth factor (VEGF) in breast cancer: comparison of plasma, serum, and tissue VEGF and microvessel density and effects of tamoxifen.
2000
HER2 (neu) Signaling Increases the Rate of Hypoxia-Inducible Factor 1α (HIF-1α) Synthesis: Novel Mechanism for HIF-1-Mediated Vascular Endothelial Growth Factor Expression
2001 StandoutNobel
Physiological coupling of growth factor and steroid receptor signaling pathways: estrogen receptor knockout mice lack estrogen-like response to epidermal growth factor.
1996
Mechanisms of Estrogen Action
2001 Standout
Regulation of Angiogenic Growth Factors in the Female Reproductive Tract by Estrogens and Progestins
1999
Inositol Polyphosphate Multikinase Inhibits Angiogenesis via Inositol Pentakisphosphate-Induced HIF-1α Degradation
2017 StandoutNobel
Overexpression of vascular endothelial growth factor by MCF-7 breast cancer cells promotes estrogen-independent tumor growth in vivo.
2003
Global Uterine Genomics in Vivo: Microarray Evaluation of the Estrogen Receptor α-Growth Factor Cross-Talk Mechanism
2004
The Effects of Plant Flavonoids on Mammalian Cells:Implications for Inflammation, Heart Disease, and Cancer
2000 Standout
Signal transduction growth factors: the effective governance of transcription and cellular adhesion in cancer invasion
2017
Phase III Trial Evaluating the Addition of Bevacizumab to Endocrine Therapy As First-Line Treatment for Advanced Breast Cancer: The Letrozole/Fulvestrant and Avastin (LEA) Study
2015
Estrogen Receptor Mutations in Human Disease
2004
Prostaglandin E2 Induces Degranulation-Independent Production of Vascular Endothelial Growth Factor by Human Mast Cells
2004
Molecular Cues to Implantation
2004
VASCULAR ENDOTHELIAL GROWTH FACTOR EXPRESSION AND TUMOR ANGIOGENESIS ARE REGULATED BY ANDROGENS IN HORMONE RESPONSIVE HUMAN PROSTATE CARCINOMA: : EVIDENCE FOR ANDROGEN DEPENDENT DESTABILIZATION OF VASCULAR ENDOTHELIAL GROWTH FACTOR TRANSCRIPTS
2001
Phase III Trial Evaluating Letrozole As First-Line Endocrine Therapy With or Without Bevacizumab for the Treatment of Postmenopausal Women With Hormone Receptor–Positive Advanced-Stage Breast Cancer: CALGB 40503 (Alliance)
2016
Angiogenesis in Endocrine Tumors
2003
Differential Ligand Activation of Estrogen Receptors ERα and ERβ at AP1 Sites
1997 StandoutScience
Antiestrogens and Selective Estrogen Receptor Modulators as Multifunctional Medicines. 2. Clinical Considerations and New Agents
2003
n-Propyl gallate activates hypoxia-inducible factor 1 by modulating intracellular oxygen-sensing systems
2008 StandoutNobel
Role of the Vascular Endothelial Growth Factor Pathway in Tumor Growth and Angiogenesis
2004 Standout
Mechanism of Action and In Vivo Role of Platelet-Derived Growth Factor
1999 Standout
Works of Constance Chiappetta being referenced
Interaction of human estrogen receptors α and β with the same naturally occurring estrogen response elements
1999
The Protooncogene c- jun Contains an Unusual Estrogen-inducible Enhancer within the Coding Sequence
1995
Pharmacological and endogenous progestins induce vascular endothelial growth factor expression in human breast cancer cells
2001
Estrogen Regulation of c-fosMessenger Ribonucleic Acid
1988
Elevation of protooncogene messenger RNAs in estrogen-induced kidney tumors in the hamster
1992
The 3′-flanking region of the mouse c-fos gene contains a cluster of GGTCA hormone-response like elements
1998
Selective inhibition of estrogen-regulated gene expression in vivo by the pure antiestrogen ICI 182,780.
1997
Uterine expression of vascular endothelial growth factor is increased by estradiol and tamoxifen.
1996
Identification of functional estrogen response elements in the gene coding for the potent angiogenic factor vascular endothelial growth factor.
2000